Moleculin Biotech, Inc.
MBRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $494 | $117 | $2 | $144 |
| - Cash | $7 | $8 | $8 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $488 | $110 | -$5 | $140 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$25 | -$8 | -$6 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$25 | -$8 | -$6 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -17 | -12.25 | -1,722 | -14 |
| % Growth | -38.8% | 99.3% | -12,200% | – |
| Operating Cash Flow | -$7 | -$6 | -$5 | -$5 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$7 | -$6 | -$5 | -$5 |